Valuation: GSK plc

Market Cap 75.75B 103B 88.57B 82.86B 143B 9,896B 144B 980B 381B 4,969B 388B 380B 16,441B P/E 2026 *
14.3x
P/E 2027 * 11.7x
Enterprise Value 95.59B 130B 112B 105B 180B 12,487B 182B 1,237B 481B 6,270B 490B 479B 20,747B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.61x
Free-Float
92.75%
Yield 2026 *
3.68%
Yield 2027 * 3.96%
1 day-1.46%
1 week+2.11%
Current month-2.12%
1 month-1.51%
3 months-1.28%
6 months-14.11%
Current year+3.62%
1 week 1,873
Extreme 1873
1,937
1 month 1,803
Extreme 1803
2,096
Current year 1,690
Extreme 1690
2,282
1 year 1,440.29
Extreme 1440.2896
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer 52 2025-12-31
Director of Finance/CFO 64 2023-04-30
Compliance Officer - 2018-07-31
Director TitleAgeSince
Director/Board Member 52 2026-05-05
Director/Board Member 64 2017-12-31
Chairman 67 2019-08-31
Date Insider Type Main position Quantity % Market Cap.
7/29/26 Sell

Executive/Senior Manager

-38,000 0.0009%
7/22/26 Buy

Executive/Senior Manager

9 0.0000%
7/14/26 Buy

Chief Technology Officer

660 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%+2.11%+27.78%+37.83% 105B
-0.67%+5.39%+75.21%+127.54% 1,119B
+1.04%+4.07%+52.29%+65.39% 651B
-0.17%+5.67%+25.60%+80.40% 468B
-1.38%+4.02%+41.64%+42.38% 374B
-0.52%+2.72%+24.32%+41.06% 302B
-1.06%+4.76%+1.19%+12.65% 259B
+1.03%+5.83%+51.11%+72.96% 238B
-0.53%+2.34%-17.77%-53.66% 208B
+0.42%+5.63%+27.86%+92.24% 181B
Average -0.33%+4.54%+30.92%+51.88% 390.46B
Weighted average by Cap. -0.27%+4.87%+43.50%+72.05%

Financials

2026 *2027 *
Net sales 33.94B 46.3B 39.68B 37.12B 64.04B 4,433B 64.72B 439B 171B 2,226B 174B 170B 7,365B 35.52B 48.45B 41.52B 38.85B 67.02B 4,640B 67.73B 460B 179B 2,330B 182B 178B 7,708B
Net income 5.44B 7.42B 6.36B 5.95B 10.26B 710B 10.37B 70.35B 27.36B 357B 27.84B 27.24B 1,180B 6.48B 8.85B 7.58B 7.09B 12.24B 847B 12.37B 83.93B 32.63B 425B 33.22B 32.5B 1,407B
Net Debt 19.84B 27.07B 23.19B 21.7B 37.44B 2,592B 37.83B 257B 99.84B 1,301B 102B 99.42B 4,306B 17.06B 23.27B 19.95B 18.66B 32.19B 2,229B 32.54B 221B 85.86B 1,119B 87.39B 85.5B 3,703B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
26-08-24 GBX 1,890.50 -1.46% 4,927,193
26-08-21 GBX 1,918.50 -0.10% 4,820,018
26-08-20 GBX 1,920.50 +0.23% 8,381,344
26-08-19 GBX 1,916.00 +1.48% 4,490,573
26-08-18 GBX 1,888.00 +1.97% 3,706,955
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
18.90GBP
Average target price
21.69GBP
Spread / Average Target
+14.72%

Quarterly revenue - Rate of surprise